The occurrence of petechiae, bruising, and mucosal haemorrhage suggests thrombocytopenia and a platelet count will immediately establish or exclude this diagnosis. There are many causes of thrombocytopenia, particularly in adults, but in children acute leukaemia and aplastic anaemia are the most important and can be proved by marrow examination. Where these and other causes have been excluded the term idiopathic thrombocytopenia purpura is used. Preceding or concomitant infection is often blamed, particularly if of acute onset, but whatever the precipitating factor the mechanism is often the development of platelet autoantibodyl and when this has been shown the term autoimmune thrombocytopenia purpura is acceptable. Acute self limiting and chronic persistent varieties are described but whether these are individual variants of the same disease or two distinct conditions is not established because not all cases fit into these two categories. In most cases complete recovery is to be expected but the risk of dangerous haemorrhage exists and this is greatest in the early weeks of the disease, particularly in patients with acute onset and severe mucosal bleeding.2 3 
Patients and methods
Between 1950 and 1980, 181 children (91 girls, 90 boys) with unexplained thrombocytopenia aged between 4 months and 15 years were under our care. Diagnosis was based on the blood count but in recent years marrow examination has usually been carried out at presentation.
Patients were arbitrarily classified as 'acute' or ,chronic' depending simply on whether the history of bleeding before presentation was less or more than two weeks. There was a significant predominance of acute disease under the age of 2 years (P = 0-025).
Since 1962 most patients have received a five week course of corticosteroids immediately after diagnosis. Splenectomy has been considered but not necessarily carried out in patients with thrombocytopenia persisting for more than one year.
During 1981 and 1982 we attempted to see all patients for follow up study. At group.bmj.com on June 19, 2017 -Published by http://adc.bmj.com/ Downloaded from two week history of bruising and petechiae and had developed epistaxis, melaena, and haematuria two days before admission. Oral purpura and conjunctival haemorrhage were prominent features. She was treated immediately with prednisone but two days later developed generalised convulsions lasting 15 seconds followed by unconsciousness lasting several hours. She had papilloedema and retinal haemorrhage particularly on the right side. Cerebrospinal fluid was straw coloured with slight increase in protein but no cells; her electroencephalogram was normal; and neck and back stiffness persisted for several days. She survives 30 years later with a normal platelet count but a possible behaviour defect, having had a number of convictions for theft.
There was no clear cut seasonal distribution and 'chronic' cases in particular occurred equally throughout the year. Direct questioning showed preceding infection in only 55 patients: 12 rubella; 7 measles; 22 presumed upper respiratory infection; and occasional instances of chicken pox, whooping cough, and scarlet fever. Some patients had received penicillin or other antibiotics in the weeks preceding onset but most children gave no history of infection or drug intake.
Marrow examination
Marrow examination was carried out in 41 patients at the time of diagnosis. Aspirated material from the iliac crest was used for direct films and the residual fragments were cut for sections. The estimated number of megakaryocytes was based on sectioned material and was considered normal in 14 patients but increased in 27, and few if any megakaryocytes showed active platelet production. Four patients had an apparent increase of eosinophils in the marrow. Neither of these features was related to outcome.
Treatment by corticosteroids Forty seven 'acute' patients had been treated with prednisone and the results were compared with 63 historic controls matched for age, sex, and type of onset. The end result was similar for both groups; 85% of the prednisone treated patients recovered spontaneously compared with 92% of those not treated in this way. Moreover, the ultimate time of recovery was the same for both groups. Twenty one 'chronic' patients were treated with similar courses of prednisone. Five had a temporary rise in platelets but in none was this sustained.
Treatment by splenectomy Splenectomy was considered whenever thrombocytopenia persisted for at least one year. When the Prior response or otherwise to corticosteroids did not indicate response to splenectomy. Five 'acute' patients, who derived little benefit from corticosteroids all responded to splenectomy as did fifteen of 21 with 'chronic' illness.
Splenectomy is not without risk; the most important, particularly in children, being of overwhelming pneumococcal septicaemia usually within 2 to 3 years of operation. One patient in this series died from this complication and has been reported previously.5
Long term follow up study Four of the 181 patients are known to have died; one from exsanguination or disseminated intravascular coagulation shortly after onset, one from pneumococcal septicaemia within two years of splenectomy, one drowned 12 years after spontaneous recovery, and the fourth, known to have been thrombocytopenic 7 years after diagnosis, was killed in a car accident several years later. Of the remainder 158 (89%) have been seen and had blood counts performed in the past two years, 142 by us and 16 by colleagues elsewhere in Britain, Canada, or Australia. Immunoglobulin values, fluorescent antibody screen, and serum platelet antibody assays were carried out in 141 of these patients.
The interval between diagnosis and follow up was from three to 35 years and in more than half was greater than 15 years. This was unrelated to clinical type, management, or end result.
All 158 patients were normal as judged by height, weight, school performance, and ultimate employment. Their haemoglobin value was mean (SD) (2-0) g/dl; white cell count was mean (SD) 7-7 (3-2) x 109/l, and mean platelet value was more than 250 x 109/l.
No patient who remitted spontaneously or responded satisfactorily to splenectomy had further bleeding nor did any member of their immediate family. No patient had developed overt autoimmune disease nor had any member of their immediate family. Eight patients gave a history of atopic illness, asthma, eczema or hayfever.
Immunoglobulin (IgG, IgM, IgA) assays on 141 patients are given in Table 4 . There was no significant difference between the major groups nor After spontaneous recovery, 27 women have had children. None have had any problem with undue bleeding at the time of delivery and no infant has been thought to have neonatal thrombocytopenia. Four patients successfully treated by splenectomy had infants without problem but two, one who was 'cured' and one who had recurrence, had infants with neonatal thrombocytopenia, all of whom were treated with steroids and survived. Bleeding at the time of delivery was not a problem, although only one of the three deliveries was covered with prophylactic platelet transfusion. Platelet antibody in serum was detected during the one pregnancy where tests were carried out but did not reach a significant value.
Platelet antibody was detected in the serum of 10 of 38 'chronic' and in 17 of 105 'acute' patients tested at follow up. The presence of antibody was not related to the clinical type, treatment, or end result, for example it was sometimes found in patients who had remitted spontaneously or not detected in the serum of patients with persistent thrombocytopenia.
Discussion
Thrombocytopenia in children is usually idiopathic or has an easily diagnosed cause. Marrow examination is often useful in differential diagnosis but not in prognosis.
There is no accepted incidence of idiopathic thrombocytopenia in chidren. Lilleyman6 puts it at less than 10/100 000 children each year, but (if possible) this is an overestimate. A recent survey among paediatricians and haematologists in the Newcastle region suggests that idiopathic thrombocytopenia is no more common than acute leukaemia, that is 4/100 000 children each year.
Most authors recognise acute self limiting and chronic persistent forms of the disease but distinguishing criteria are not defined. Retrospective diagnosis is not helpful in planning early management and classification based on antibody or other tests has not proved reliable.4 7 For the present series we used one simple criterion. Based on a history of bruising of less or more than two weeks 75% of patients were classified as 'acute' and 25% as 'chronic', possibly an exaggeration of chronic disease due to special referral. Harrington et al' showed that plasma from affected patients, when infused into normal volunteers could produce thrombocytopenia. The transferable factor was found to be in the IgG fraction." Increased quantities of platelet associated IgG have been found on platelets of patients with idiopathic thrombocytopenia. " The IgG on the platelets seems to be monomeric and antigen specific. '23 These raised IgG concentrations have also been found in other conditions.'4 The presence of immune complexes in sera of affected patients has been reported.'t Localisation and quantitation of the site and degree of platelet destruction has been shown by the use of 'chromium and "'indium. '6 This evidence supports the concept of an autoimmune disorder. The relative importance of the findings remains to be established. At this time, however, there is no evidence that any of the investigations provide results predicative of response to treatment. McMillan'7 'x has reviewed the subject but considers it still premature to assume that idiopathic thrombocytopenia always has an immune basis.
The use of corticosteroids in idiopathic thrombocytopenia is still controversial.6 x 9"9 If 80 to 90% of affected children will remit rapidly and spontaneously perhaps steroids should be reserved for those who fail to recover quickly. The major danger exists, however, in the early weeks of the disease and therefore corticosteroids should probably be given immediately, especially when onset has been 'acute' and mucosal haemorrhage a prominent feature. In addition, it is easy to justify a trial of corticosteroids when thrombocytopenia is persistent. It is our policy, therefore, to give a five week course to all patients at presentation even though we have been unable to prove a difference in long term result and speed of recovery. If used in this way side effects of corticosteroids are negligible and diminution in active bleeding is 'apparent' even when there is no change in the platelet count. Corticosteroids improve platelet economy21' and possibly have a direct effect on capillary fragility. Long term corticosteroids have serious side effects, may potentiate thrombocytopenia ,21 and are not recommended.
One child, not in the present series, came under our care after more than two years of maintenance treatment with prednisone. When this was stopped the condition improved dramatically and three years later the platelet count is still normal.
Other immune suppressants are often tried in chronic disease but their value is usually short lived and side effects not acceptable." " 2 23 Any role for intravenous gammaglobulin has yet to be established,24 25 while plasmapheresis may find a place in the preparation of patients for surgery in acute emergencies.26
Four patients who presented with severe bleeding have almost certainly remained thrombocytopenic for as long as 20 years with minimal, if any, symptoms and even now spontaneous remission is a possibility.
What then is the role of splenectomy; either to remove the site of platelet sequestration or the primary site of antibody production?27 There may be a place for emergency splenectomy in life threatening cases 2 but most workers would consider this only when thrombocytopenia has persisted for more than one year.6 2(1 Danger of fulminating pneumococcal septicaemia after splenectomy is greatest in infancy or under the age of five years and maximal in the first two to three years after operation.28 One child in this series died at the age of 10 years within two years of operation which was performed for prolonged, but symptomless thrombocytopenia. The danger can be reduced by preoperative immunisation against pneumococci and prophylactic penicillin for at least three years after operation but splenectomy for thrombocytopenia should probably be recommended only if there is disability. Previous response to steroids or otherwise does not indicate the likely response to splenectomy and the value of studies of antibody type and platelet survival in deciding this have not been evaluated.29 The platelet response in the first two weeks after operation, however, allows a good estimate of the long term result and if values of greater than 300 x 109/l are not sustained for this period a poor response is to be expected, although exceptions occur. In this series 32 patients underwent splenectomy; 24 derived long term benefit with normal platelet counts but 8 remain thrombocytopenic. Antibody may persist after splenectomy even in patients with normal platelet counts as in one patient in the present series whose infant suffered from neonatal purpura.
As idiopathic thrombocytopenia in children is rare, it is relevant to consider whether there might be some underlying defect in immune regulation,j(32 for thrombocytopenia can be a feature of disorders such as Aldrich's syndrome in children and systemic lupus erythematosus in adults.
We have direct knowledge of 158 patients in the past two years and information on 13 others for at least 10 years after diagnosis. All who remitted spontaneously or responded optimally to splenectomy have had no further bleeding problems. None of their immediate family have had any relevant bleeding disorder. None have developed other overt autoimmune or lymphoproliferative disease, nor have any of their immediate family. Immunoglobulin values were not different from a normal population of similar age and this was true when clinical subtypes of idiopathic thrombocytopenia were considered individually. Thyroid autoantibodies were detected in four girls but this is not more than would be expected in a random, local population. Three 
